Tag: Motley Fool

The Renascor Resources Ltd (ASX: RNU) share price isn’t going anywhere on Wednesday.

That’s because this morning, the battery materials explorer requested a trading halt.

Why is the Renascor share price paused?

The Renascor share price was halted this morning so the company could undertake a fully underwritten institutional placement.

According to the release, the placement aims to raise approximately $70 million from institutional investors at 27.5 cents per share.

While this represents a 14% discount to its last close price, it is significantly higher than where the Renascor share price was trading 12 months ago, as you can see below.

Why is it raising funds?

Renascor advised that the proceeds will be used to fund the development of the Siviour Battery Anode Material (BAM) Project in South Australia.

This follows the recent approval from the South Australian Department of Energy and Mining of the Program for Environment Protection and Rehabilitation (PEPR) for its proposed Siviour Mine and Concentrator in South Australia.

Management believes the placement is another successful step toward Renascor’s goal of powering Australia’s clean energy transition through the development of its vertically integrated manufacturing operation to produce sustainable and ethically-sourced battery anode material for the lithium-ion battery market.

Renascor’s managing director, David Christensen, commented:

Renascor’s ambition is to become a reliable supplier of 100% Australian-made purified spherical graphite for lithium-ion battery anode makers worldwide. The funds raised via this Placement, together with the recently received PEPR approval, bring us significantly closer to realising this objective, as we look to accelerate our development timeline by bringing forward the commencement of construction of the Siviour mine and concentrator.

We now look forward to completing our Optimised BAM Study and ultimately reaching a Final Investment Decision next year. On behalf of Renascor board and management, I wish a warm welcome to our new shareholders and thank all our existing institutional and retail shareholders for their ongoing support.

The post Why is the Renascor Resources share price on ice today? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• These were the 3 best-performing ASX All Ords shares in November
• Top ASX shares to buy in December 2022
• Why is the Renascor Resources share price rocketing 46% this month?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/2FobBpZ

The 4DS Memory Limited (ASX: 4DS) share price streaked 32% higher shortly after the market open today.

The ASX tech share shot up following an announcement by the semiconductor memory storage company this morning before settling again in late morning trade.

The ASX tech share is currently trading at 5.1 cents, up 2%. It reached an intraday high of 6.6 cents shortly after the open.

The company went into a trading halt yesterday and also received a price query from the ASX.

What’s the news that launched this ASX tech share skywards?

4DS has updated shareholders on its 2023 collaboration with imec this morning.

The company said it has finalised arrangements to extend the collaboration project into mid-2023. The cost will be 903,000 euros.

4DS said manufacturing of the Fourth Platform Lot will commence in Q1 2023. The company expects delivery at the end of Q2 2023.

4DS Memory is a semiconductor development company of non-volatile memory technology.

imec is a world-leading research and innovation hub in nanoelectronics and digital technologies.

What did management say?

4DS Memory executive chair Dr Wilbert van den Hoek said:

We are extremely pleased to have reached agreement with imec for an extension of our collaboration into 2023.

We will continue to undertake internal activities, the results of which will be inputs to the collaboration during 2023. Furthermore, we are continually improving our testing capability to ensure that we are best placed for a potentially successful outcome.

What has 2022 been like for this ASX tech share?

The 4DS Memory share price is down 42% in 2022.

This performance is on par with the information technology index, which is down 34% year to date.

The post Why did this ASX tech share just explode 30%? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Strike Energy share price soars following Warrego buy up
• Fortescue share price jumps amid Twiggy’s $4b renewables takeover
• ASX 200 correction: A once-in-a-lifetime chance for supercharged passive income!
• Why is the CSL share price in the spotlight on Wednesday?
• With $5,000 to invest, I’d aim to make a 1,000% return from ASX shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/715cDiO

The Strike Energy Ltd (ASX: STX) share price is soaring on Wednesday, up 5%.

Strike Energy shares closed at 34 cents yesterday and are currently trading for 36 cents apiece.

Investors are bidding up the ASX energy share following an update on its increased ownership of Warrego Energy Ltd (ASX: WGO) and the West Erregulla gas field, located in Western Australia.

Here’s what the company reported.

What’s happening with Warrego Energy?

The Strike Energy share price is soaring, and the Warrego Energy share price is up 3.2% after Strike said it is increasing its shareholding in Warrego to approximately 19.9%.

This was accomplished via share purchase agreements with a number of Warrego stockholders via the swap of Strike shares for Warrego shares at a 1:1 share exchange ratio.

Once the share swaps are settled, Strike will be the largest shareholder in Warrego, with around 19.9% voting rights.

The Strike share price could also be getting some tailwinds as this will see the company increase its ownership of the West Erregulla gas field to some 60%.

Warrego has been the subject of an ongoing takeover battle that’s helped drive the Warrego share price up 103% over the past month.

Atop Strike Energy, two other powerhouses – Beach Energy Ltd (ASX: BPT) and Gina Rinehart’s Hancock Energy – have been seeking to gain controlling ownership of Warrego’s gas assets.

Perhaps with this in mind, Strike’s board stressed it had not yet “formed any intention with regards to any future transaction that may involve Warrego”. The company said it is considering all available strategic options.

Commenting on the Warrego buy up driving the Strike Energy share price higher today, CEO Stuart Nicholls said:

Strike has a strong track record of identifying and securing valuable and strategic energy assets at various stages of maturity. The expansion of our ownership of Warrego shares and the resulting look through to an increased economic interest in the West Erregulla gas field is a further demonstration of this.

Strike Energy share price snapshot

The Strike Energy share price is up an impressive 122% over the past 12 months, with Warrego shares having leapt 171% higher. For some context, the All Ordinaries Index (ASX: XAO) is down 2% over that same period.

The post Strike Energy share price soars following Warrego buy up appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 5 things to watch on the ASX 200 on Wednesday
• Here’s why the Beach Energy share price is diving 6% on Tuesday
• Why Beach, Block, Magellan, and St Barbara shares are dropping
• 5 things to watch on the ASX 200 on Tuesday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/AdaYuNZ

The Fortescue Metals Group Limited (ASX: FMG) share price is higher this morning. Meanwhile, the company’s boss is hitting headlines following a major renewable energy acquisition.

Squadron Energy, owned by the iron ore giant’s founder and chair Andrew ‘Twiggy’ Forrest’s investment vehicle Tattarang, has snapped up CWP Renewables for a widely reported sum of $4 billion.

Squadron Energy is entirely separate to Fortescue. Still, the news might have turned the market’s attention to the S&P/ASX 200 Index (ASX: XJO) giant.

Right now, the Fortescue share price is $20.96, 1.26% higher than its previous close.

For comparison, the ASX 200 has fallen 0.71% at the time of writing. Simultaneously, the S&P/ASX 200 Materials Index (ASX: XMJ) has lifted 0.36% – making it today’s best-performing sector so far.

Let’s take a closer look at the announcement putting Forrest in the spotlight on Wednesday.

Twiggy snaps up renewable energy giant in $4b takeover

The Fortescue share price is outperforming amid news a massive acquisition has seen Squadron dubbed Australia’s largest renewable energy investor, operator, and developer.

Forrest’s privately-owned company officially bought CWP Renewables today, bringing its renewable energy operating portfolio to 2.4 gigawatts. It also now boasts an Aussie development pipeline of 20 gigawatts.

Once fully operational, Squadron’s portfolio will be capable of powering 8.5 million homes.

Forrest commented on the takeover, saying:

Australian industries’ ability to consign fossil fuel to history, is robustly demonstrated by the strong track record and commitment of Fortescue Metals, Fortescue Future Industries, and other world-leading companies committed to decarbonising.

We share a vision of Australia and the world, looking back on the dark era of fossil fuel as an aberration in humanity’s history. One that could have ended with that fuel, but is now powered by cheap, pollution-free, democratic, inexhaustible energy.

CWP provides renewable energy to ASX 200 giants Woolworths Group Ltd (ASX: WOW), Transurban Group (ASX: TCL), and Commonwealth Bank of Australia (ASX: CBA).

Squadron beat out AGL Energy Ltd (ASX: AGL)’s Tilt Renewables for the acquisition, The Australian reports. Tilt was taken over by AGL’s part-owned platform PowAR – since renamed Tilt – last year.  

Fortescue share price snapshot

The Fortescue share price has outperformed over the course of 2022.

The stock is currently 6% higher than it was at the start of this year. It has also gained 20.5% since this time last year.

For comparison, the ASX 200 has slumped 5% year to date and 1% over the last 12 months.

The post Fortescue share price jumps amid Twiggy’s $4b renewables takeover appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Bought $1,000 of CBA shares 10 years ago? Here’s how much dividend income you’ve received
• 10 ASX shares to buy in 2023
• What’s the outlook for the iron ore price in 2023?
• 5 popular ASX 200 stocks I’m avoiding, plus one that still looks dirt cheap
• What’s in store for the Woolworths share price in December?

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/0C9Hm1L

The S&P/ASX 200 Index (ASX: XJO) itself hasn’t fallen that much in 2022. But a number of businesses fell much harder than the index, with the effect of significantly boosting their dividend yield.

There have been points in the year where the ASX 200 was down around 15%. While some names within the index were down further.

Example of how dividend yield is boosted

If an ASX 200 dividend share had a 5% yield and then the share price drops 10%, this would turn the yield into 5.5% for new investors.

A fall of 20% would mean the 5% yield turns into a 6% yield for investors buying shares.

A decline of 30% means the 5% yield is boosted to 6.5%.

And so on.

Of course, those yields are only correct if the dividend is at least maintained.

But, it can make a big difference to how much dividend cash is produced.

A $5,000 investment with a 5% dividend yield generates $250 of annual dividend income.

A $5,000 investment with a 6.5% dividend yield makes $325 of annual dividend income.

Which ASX 200 shares have seen a big dividend yield jump?

Some businesses have suffered declines, and their dividends may remain largely intact. But, be wary of some yields that could be dividend traps. In other words, the dividends in the last financial year may be nowhere near as good as the next financial year.

Domino’s Pizza Enterprises Ltd (ASX: DMP) shares have declined by around 45% in 2022 to date. According to the CommSec estimate, Domino’s is projected to pay an annual dividend of $1.50 per share in FY23, translating into a grossed-up dividend yield of around 3%.

Pinnacle Investment Management Group Ltd (ASX: PNI) – the outfit that invests in fund managers – has seen its share price also decline by around 45%. It’s projected to pay an annual dividend per share of 32 cents in FY23 according to CommSec. This translates into a forward grossed-up dividend yield of 5.2%.

Premier Investments Limited (ASX: PMV) – the owner of Smiggle, Peter Alexander and Just Jeans – has seen a share price drop of almost 20% in 2022. CommSec estimates suggest an annual dividend of $1.01 per share, which translates into a grossed-up dividend yield of 5.75%.

Foolish takeaway

Investors that can take advantage of lower ASX 200 share prices and higher dividend yields give themselves the opportunity of ramping up their passive income at a much quicker rate than what was achievable in 2021.

The post ASX 200 correction: A once-in-a-lifetime chance for supercharged passive income! appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why is the CSL share price in the spotlight on Wednesday?
• 10 ASX shares to buy in 2023
• Here are the top 10 ASX 200 shares today
• 7% dividend yield! One ASX 200 share to buy in December and hold for 10 years
• Here are the 3 most heavily traded ASX 200 shares on Tuesday

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Pinnacle Investment Management Group. The Motley Fool Australia has positions in and has recommended Pinnacle Investment Management Group. The Motley Fool Australia has recommended Domino’s Pizza Enterprises and Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/J75Xrw3

The CSL Limited (ASX: CSL) share price is down this morning at $299.54, 0.42% below yesterday’s close.

Meantime, the S&P/ASX 200 Index (ASX: XJO) is also down 0.66%.

Today is the official opening day for CSL’s brand new $900 million blood plasma processing plant at its existing manufacturing site in Melbourne.

New plant enables a 9-fold increase in production

According to The Australian, the plant represents about half of CSL’s current capital investment budget in Australia. The benefit will be a nine-fold increase in the company’s Australian plasma processing capacity.

This means more products can be made and sold, inevitably boosting earnings for the company.

CSL collects plasma from blood donors to make blood therapy treatments for people with immunodeficiencies, neurological disorders, shock, and burns. They are also used for transfusions in hospitals.

To make these biotherapies, the plasma needs to be separated into its individual components. This process is called fractionation and that’s what will happen at the plant.

What does management say?

CSL CEO Paul Perreault said the plant “ensures we are developing the skills and expertise locally to support advanced manufacturing in Australia”.

He said:

Over the past 10 years, CSL has invested close to $2bn into Broadmeadows, helping transform the site into an important part of CSL’s global manufacturing network and a significant contributor to the company’s success in the decades to come.

CSL has also built a second new fractionation facility in Marburg, Germany at the same time.

Also in Melbourne, CSL is in the midst of constructing a next-generation influenza vaccine manufacturing facility at Tullamarine. The facility will use cell-based technology to create vaccines.

CSL is also building a new global headquarters and a research and development centre.

Brokers say buy on CSL share price

CSL has been attracting a lot of broker love lately. Many analysts think the CSL share price is a buy.

Wilson Asset Management equity analyst Anna Milne says CSL is her top ASX healthcare share pick for 2023 and “a stock that’s hard to fault“.

Wilsons is tipping a 12-month share price target of $327 and has an overweight rating.

As my colleague James reports, Citi says buy with a share price target of $340. Macquarie has an outperform rating with a price target of $343.

CSL has been in the headlines lately following the United States Food and Drug Administration’s approval of its new haemophilia B treatment, Hemgenix.

It’s the first and only one-time gene therapy for adult patients and will replace weekly treatments for many patients.

CSL will reportedly sell it for US$3.5 million per dose, making it the world’s most expensive drug.

The post Why is the CSL share price in the spotlight on Wednesday? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• If you bought 100 shares of CSL 10 years ago, this is how much you would have today
• To retire early, I’d invest $100 each week in ASX 200 shares
• Here are the top 10 ASX 200 shares today
• 7% dividend yield! One ASX 200 share to buy in December and hold for 10 years
• Here are the 3 most heavily traded ASX 200 shares on Tuesday

Motley Fool contributor Bronwyn Allen has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Qd8D0Y7

If I had $5,000 burning a hole in my pocket and an aspiration to make a 1,000% return, I’d turn to the ASX and the shares that call it home.

There’s no guaranteed path to turn $5,000 into $55,000, but there are a few strategies I would consider using if I were aiming for such an astronomical return.

Investing in future 10-bagger ASX shares

The first is that which might come to mind quickest – investing in a share, or many, capable of gaining 1,000% or more.

That’s certainly possible. ASX shares posting such gains over the last few years include lithium favourite Core Lithium Ltd (ASX: CXO), homewares retailer Temple & Webster Group Ltd (ASX: TPW), and software provider IODM Ltd (ASX: IOD).

In fact, the latter tech share has posted a gain of more than 4,000% over the last five years.

However, identifying future 10-baggers is far more difficult than scrounging up past winners.

If I were hunting for stocks potentially capable of rising 1,000%, I would start my search among the smaller end of town. There, I would look for shares in businesses I truly believe could make it. Personally, I would focus on those boasting a healthy balance sheet and a major competitive edge.

However, investing in stocks that look like they could be future multi-baggers generally demands a lot of patience and time. It also comes with a huge side of risk.

Thus, it’s likely that I would miss my 1,000% target or even lose money if some of my picks underperform against my expectations.

Using Peter Lynch’s strategy

Another approach I might consider when seeking a 1,000% return by investing in ASX shares would start at the other end of town. That is a strategy touted by investing great Peter Lynch – investing in ‘stalwarts’.

Stalwarts are generally larger companies, like S&P/ASX 200 Index (ASX: XJO) shares, that haven’t quite met their growth potential. Thus, they may be capable of moderately outperforming the market over a few years.

After a company’s expected growth was realised, Lynch would sell out and reinvest in a new stalwart, thereby compounding returns. It’s widely reported that Fidelity’s Magellan fund returned an annual average of around 29% under Lynch’s control.

If I could realise such a return, which is far from guaranteed, I could turn $5,000 into more than $55,000 in around 10 years. That’s the power of compounding!

Take advantage of index funds

The final tactic I would consider is buying shares in an index fund tracking the ASX 200. This approach offers the least risk of the three.

Combining capital returns and dividends, the ASX 200 returned 9.3% on average over the 10 years to 2021.

While past performance doesn’t indicate future performance, such a return could turn a $5,000 initial investment into $55,000 in 27 years.

The post With $5,000 to invest, I’d aim to make a 1,000% return from ASX shares appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Here are the 3 most heavily traded ASX 200 shares on Tuesday
• Why are ASX 200 lithium shares taking a lashing today?
• Is Core Lithium the hottest stock on the ASX 200 right now?
• Can ASX 200 lithium shares come charging back in December?
• Here are the 3 most heavily traded ASX 200 shares on Monday

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/WKTslnN

In morning trade, the Santos Ltd (ASX: STO) share price is edging lower.

At the time of writing, the energy producer’s shares are down 0.7% to $7.20.

While disappointing, this compares favourably to other energy shares which are falling heavily after oil prices sank overnight.

Why is the Santos share price outperforming peers?

The Santos share price is faring better than peers such as Beach Energy Ltd (ASX: BPT) today thanks to the release of a positive announcement which has partially offset the oil price weakness.

According to the release, Santos has announced a simplified capital management framework targeting higher shareholder returns. This includes a minimum annual return of at least 40% of free cash flow.

Santos notes that its strategy is to maintain a disciplined, low-cost operating model that is designed to deliver strong cash flows through the commodity price cycle.

This revised capital management framework seeks to maintain an appropriate capital structure that enables Santos to balance the allocation of capital between investment in the business to develop backfill projects, decarbonisation projects, the development of strategic growth and clean fuels projects, and the provision of sustainable returns to shareholders based on the generation of free cash flow.

What is the capital management framework?

Santos’ capital management framework is as follows:

• A policy of at least 40% payout of free cash flow from operations (excluding major growth) generated per annum.
• Shareholder returns by way of cash dividends and/or share buybacks, subject to market conditions and board discretion.
• An unchanged target gearing range of 15% to 25%.

Share buyback boost

Also lending some support to the Santos share price today is news that the company is boosting its share buyback.

Santos has announced a further US$350 million increase in its on-market share buyback. This amount is in addition to the US$350 million announced in August 2022, which is approximately 98% complete, and brings the total on-market share buyback amount to US$700 million for 2022.

Santos’ Chair, Keith Spence, revealed that this may not be the end of shareholder returns and that 40% of free cash flow may not be its payout ratio minimum for long. He said:

In addition, the Board shall give consideration to additional shareholder returns from any net proceeds derived from asset divestments through portfolio optimisation once those divestments reach completion and proceeds have been received.

Once the Barossa and Pikka Phase 1 projects commence production, the Board’s intention is to consider increasing shareholder returns to at least 50 per cent of free cash flow generated per annum.

The post Santos share price falls despite some big news for shareholders appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 5 things to watch on the ASX 200 on Tuesday
• Why Imugene, Rio Tinto, Santos, and Warrego shares are pushing higher
• 5 things to watch on the ASX 200 on Monday
• Could our dividends now be too reliant on ASX 200 oil shares?
• 5 things to watch on the ASX 200 on Thursday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/u8PiELC

The CSL Limited (ASX: CSL) share price has been a very strong performer for investors over the last ten years.

For investors that don’t know, CSL is the biggest ASX healthcare share. CSL describes itself as one of the largest and fastest-growing protein-based biotechnology businesses and a leading provider of in-licensed vaccines.

CSL Plasma operates one of the world’s largest plasma collection networks, with over 300 collection centres worldwide.

It also recently acquired the Vifor business, which is now called CSL Vifor. This business is focused on iron deficiency and nephrology.

At the time of writing it has a market capitalisation of $145 billion. But, it wasn’t always the giant that it is now.

Strong growth

A decade ago the CSL share price closed at $54.77. That means the cost to buy 100 CSL shares would have been $5,477.

CSL has gone through a lot since then.

It was almost a decade ago that the current CSL CEO and managing director Paul Perreault was appointed as the CEO and managing director. He stepped up from the role of President of the CSL Behring division.

CSL announced the influenza vaccine business of Novartis for just US$275 million in October 2014, creating the vaccine division called Seqirus. The name comes from the term “securing health for all of us”.

It has made a number of other acquisitions including Vifor most recently.

The company also transitioned to an ‘own distributor’ model in China.

Throughout this time, the business has grown strongly organically and invested billions of dollars in research and development. In FY22 it spent $1.16 billion on R&D. This helps the business create new life-changing healthcare products and unlock new earnings streams.

In FY12, the business made A$983 million of net profit after tax (NPAT). In FY22 it generated US$2.375 billion of NPAT, or A$3.54 billion at the current exchange rate to compare apples to apples for that growth over a decade.

Growth of the CSL share price

The CSL share price is now valued at $300.79. That means that it has gone up 449%.

For an initial cost of $5,477, those same 100 shares would now be worth $30,079. That’s a big gain and doesn’t account for the dividends that it has paid either.

The FY22 full-year dividend was US$2.22 per share, which is approximately AU$3.33 per share at the current exchange rate, though it was A$3.11 at the time of announcement. That means the dividend yield on cost for those 100 shares equates to a dividend yield of 6%.

Can it keep rising?

Share prices tend to follow profits over time, so if CSL can keep growing then it can keep generating shareholder returns.

The broker Macquarie has a price target of $343, which implies a possible rise of 14% over the next 12 months.

Citi has a price target of $340 on the ASX healthcare share, which implies a possible rise of 13%.

The post If you bought 100 shares of CSL 10 years ago, this is how much you would have today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• To retire early, I’d invest $100 each week in ASX 200 shares
• 5 popular ASX 200 stocks I’m avoiding, plus one that still looks dirt cheap
• Is Core Lithium the hottest stock on the ASX 200 right now?
• Is the CSL share price set to take off in December?
• Why CSL shares are this fundie’s top ASX 200 healthcare pick

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/gA94Yj5

Shares in Commonwealth Bank of Australia (ASX: CBA) have been an ASX dividend staple since 1991. The $180 billion bank share is also Australia’s second-largest listed company.

Right now, CBA shares are trading at $106.44, having smashed through the milestone $100 mark in May 2021. That sees the stock 3.8% higher than it was at the start of this year.

For comparison, the S&P/ASX 200 Index (ASX: XJO) has fallen 3.9% year to date.  

But if we were to rewind further back, 10 years to be exact, CBA shares were worth around $61.40 apiece. If an investor bought $1,000 worth of CBA stock back then, they likely would have walked away with 16 securities and $17 change.

The CBA share price has gained 73% since then, leaving our figurative parcel of shares valued at $1,703.04. And that’s before considering the dividends offered by the banking giant.

How much have CBA shares paid in dividends in 10 years?

Here are all the dividends handed out to those invested in CBA shares over the last decade:

CBA dividends’ pay date	Type	Dividend amount
September 2022	Final	$2.10
March 2022	Interim	$1.75
September 2021	Final	$2
March 2021	Interim	$1.50
September 2020	Final	98 cents
March 2020	Interim	$2
September 2019	Final	$2.31
March 2019	Interim	$2
September 2018	Final	$2.31
March 2018	Interim	$2
September 2017	Final	$2.30
April 2017	Interim	$1.99
September 2016	Final	$2.22
March 2016	Interim	$1.98
October 2015	Final	$2.22
April 2015	Interim	$1.98
October 2014	Final	$2.18
April 2014	Interim	$1.83
October 2013	Final	$2
April 2013	Interim	$1.64
Total:		$39.29

Anyone who invested in CBA stock in December 2012 and held tight over the years since may be happy to learn they’ve likely received $39.29 for every share they hold.

That means an assumed $1,000 initial investment 10 years ago has provided $628.64 in dividends. That’s nearly the same amount offered by BHP Group Ltd (ASX: BHP) shares in that time!

Considering both capital appreciation and dividends, $1,000 worth of CBA shares a decade ago could have doubled an investor’s money in the years since. Those 16 stocks could have returned $1,331.68 on top of the figurative initial investment.

And that’s all without using a dividend reinvestment plan (DRP) to compound CBA’s dividends.

Finally, all offerings from the bank in that time were fully franked. Thus, they might have provided additional value come tax time.

CBA shares currently offer a 3.6% dividend yield.

The post Bought $1,000 of CBA shares 10 years ago? Here’s how much dividend income you’ve received appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 5 popular ASX 200 stocks I’m avoiding, plus one that still looks dirt cheap
• Is Core Lithium the hottest stock on the ASX 200 right now?
• Almost ready to retire? Why I’d buy undervalued ASX dividend shares right now
• Should CBA shares be in your ASX stocking in December?
• The 3 best-performing ASX 200 bank shares in November revealed

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/F8ubNyR